- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$0.46 BnMarket Estimate, 2026
$0.48 BnMarket Forecast, 2034
$0.68 BnCAGR, 2026–2034
4.5%Executive Summary: North America Perfusion Systems Market
- Market Scope: Regional analysis of North America's perfusion systems sector, detailing component frameworks, system types, preservation techniques, and country-level profiles from 2026 to 2034.
- Market Valuation: Valued at USD 0.48 billion in 2026, and projected to expand to USD 0.68 billion by 2034, growing at a robust CAGR of 4.50% from 2026 to 2034.
- Primary Growth Drivers: Increasing volume of organ transplantation surgeries, rising incidence of multiple organ failures, growing organ donor awareness initiatives, and introduction of advanced perfusion technologies.
Key Market Segment Metrics
| Category | Leading Segment (Base Position) | Fastest-Growing / High-Growth Segment |
|---|---|---|
| By Component | Heart-Lung Machines & Oxygenators (dominated market share due to essential use in cardiac surgeries) | Monitoring Systems (anticipated at a higher growth pace fueled by real-time safety tracking needs) |
| By Type | Bioreactor Perfusion Systems (held major market share supported by widespread biomedical applications) | Microfluidic Perfusion Systems (recorded at the highest growth rate driven by tissue engineering and organ-on-chip advances) |
| By Technique | Hypothermic Machine Perfusion (captured major share in routine organ preservation and transport) | Normothermic Machine Perfusion (fastest-growing segment propelled by functional organ assessment capabilities) |
| By Country | United States (market leader backed by advanced healthcare infrastructure and high transplant volumes) | Canada (key high-growth hub supported by specialized clinical trial centers and structured regulations) |
Major Market Players & Industry Landscape
Market Structure: Highly competitive medical technology environment featuring major multinational device manufacturers delivering integrated cardiopulmonary bypass systems and advanced organ preservation platforms.
Key Companies: Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, and XENIOS AG.
Download Free Sample Report
North America Perfusion Systems Market Size
The North America Perfusion Systems Market is projected to grow from USD 0.46 billion in 2025 to USD 0.48 billion in 2026 and reach USD 0.68 billion by 2034, registering a CAGR of 4.50% during the forecast period from 2026 to 2034.
The increase in the number of transplantation surgeries happening in the North American countries is significantly boosting the perfusion systems market in this region. As per the statistics published by the U.S. Department of Health and Human Services, over 119,000 people are in the queue for transplantations, and only 2,555 donors are obtainable as of April 2017. They are predicted to rise more in the forthcoming years. Growing gaps between the demand and supply, the rise in the number of approvals, and the introduction of novel perfusion systems are further encouraging the growth rate of the market in the forthcoming years. For instance, nearly 100,791 people in the United States have geared up for kidney transplants, as per the report announced by the National Kidney Foundation as of 2016. More than 117,000 males, females, and children were on the national transplant standby till July 2017, and 17,155 organ transplants were implemented in the U.S., according to the Organ Procurement and Transplant Network (OPTN).
Pressure for efficient perfusion systems is accelerating by the growing number of organ failures because of alcohol consumption, improper diet, and smoking is accelerating the need for these systems in North America. According to the approximations created by the National Institute of Diabetes and Digestive and Kidney Diseases, 661,000 people were registered for kidney failure in the U.S. For instance, METRA developed by OrganOx Ltd. used for automatic liver transplantation and normothermic liver perfusion is still under clinical trials in the United States. Technically invented products for the sake of developed efficacy and economy are expected to produce profitable opportunities in the region.
The high costs associated with organ transplantation is a prime factor hindering the market growth. Also, behavioral issues and tough competition from the domestic key players with less-cost products hamper the perfusion systems market growth in North America. People with less or no knowledge about the perfusion systems market are another factor impeding the region's growth.
MARKET SEGMENTATION
This research report on the North America Perfusion Systems Market has been segmented and sub-segmented into the following categories
SEGMENTAL ANALYSIS
By Component Insights
-
Heart-lung Machines
-
Perfusion Pumps
- Oxygenators
- Monitoring Systems
- Cannulas
By Type Insights
-
Bioreactor Perfusion Systems
-
Microfluidic Perfusion Systems
- Gravity/Pressure-driven Perfusion Systems
- Small-mammal Organ Perfusion Systems
By Technique Insights
-
Hypothermic Machine Perfusion Systems
-
Normothermic Machine Perfusion Systems
Country Level Analysis
- The United States
- Canada
- Rest of North America
Based on the region, North America has the highest no. share in this market. The USA has the highest demand, followed by Canada and Mexico. The North American region is primarily driven by environmental concerns.
U.S and Canada are the foremost leading nations in the region, contributing the majority of the total market share. Amplifying the number of chronic diseases regarding lungs, heart, liver, and kidneys escalate the region's market. The fructifying number of heart and kidney bypass surgeries and people having more knowledge about the surgeries to be performed using advanced technologies are prompting the perfusion systems market's growth rate in North America.
The burgeoning pervasiveness of coronary diseases adjacent to the quick approval of modern technologies and devices utilized in the surgical procedures flourish the market growth. The United States is leading the perfusion systems market, as most key players are engaged in elaborating novel products utilized in clinical trials.
The U.S. government has taken some initiatives from nonprofit organizations like Donate Life America to bring awareness to people, which escalates market growth.
KEY MARKET PLAYERS AND COMPETITIVE LANDSCAPE
Promising Companies leading the North America Perfusion Systems Market Profiled in the Report are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, XENIOS AG, Repligen Corporation, Spectrum Laboratories, Inc, Merck KGaA, Harvard Bioscience, Inc, ALA Scientific Instruments, Inc.,